Osteoporosis in Post-menopausal Women
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
HELP TherapeuticsChina - Nanjing
1 program1
Human Umbilical Cord-derived Mesenchymal stem cellPhase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2025
2026
HELP TherapeuticsHuman Umbilical Cord-derived Mesenchymal stem cell
Clinical Trials (1)
Intravenous Infusion of Human Mesenchymal Stem Cells (HMM910 ) in Postmenopausal Women With Osteoporosis at High Risk of Fracture
Start: Jun 2025Est. completion: Sep 2026
Phase 1Active Not Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space